UnitedHealth Group Incorporated (unh)
UNH — Company Overview
Investors tracking UNH follow a Healthcare Plans name listed on NYQ within Healthcare.
| Ticker | UNH |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Exchange | NYQ |
| Market cap | $366.86B |
| Last price | $403.97 |
| Size category | Mega Cap |
UNH — Business Description
The business profile of UnitedHealth Group Incorporated (UNH) reflects its role in Healthcare Plans. UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment…
Official website: https://www.unitedhealthgroup.com.
UNH — Investment Thesis
UnitedHealth Group Incorporated (UNH) attracts investors weighing Healthcare Plans fundamentals against current market pricing.
- Revenue is expanding at roughly 0.4% year-over-year (public data).
- Trailing P/E of 31.05× sits in a moderate band relative to high-growth peers.
- Forward P/E (18.01×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 2.2% adds an income component to total return.
- Equity market capitalization is approximately $366.86B.
Analyst consensus, price targets & estimates is available in Vest Terminal for Professional and Enterprise subscribers.
UNH — Financial Health
UNH financial profile reflects operating efficiency and capital structure using available market fundamentals.
Profit margin near 3.1% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $22.76B supports balance-sheet flexibility.
| Trailing P/E | 31.05× |
| Forward P/E | 18.01× |
| Price / Sales | 0.82× |
| Price / Book | 3.50× |
| Gross margin | 19.5% |
| Operating margin | 7.1% |
| Profit margin | 3.1% |
| Return on equity | 14.2% |
| Debt / Equity | 69.21 |
| Free cash flow | $22.76B |
UNH — Growth Outlook
Growth outlook for UnitedHealth Group Incorporated (UNH) depends on demand trends in Healthcare Plans and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 0.4% suggests steady but measured expansion.
- Earnings growth of 61.5% year-over-year supports improving profitability.
- Price is 12.5% below the 52-week high.
UNH — Competitive Position
UnitedHealth Group Incorporated (UNH) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Healthcare Plans.
- Market capitalization of $366.86B places UNH among mega-cap peers.
- Gross margin of 19.5% should be benchmarked against direct competitors.
UNH — Strengths
Strengths for UnitedHealth Group Incorporated (UNH) inferred from public financial metrics:
- Earnings growth of 61.5% year-over-year.
- Positive free cash flow ($22.76B).
- Dividend yield of 2.2% for income-oriented holders.
- Moderate leverage (debt/equity 69.21).
- Mega Cap scale ($366.86B) may provide distribution and funding advantages.
UNH — Weaknesses
Weaknesses and pressure points for UnitedHealth Group Incorporated (UNH) based on available data:
- Thin profit margin (3.1%).
UNH — Opportunities
- Dividend yield of 2.2% appeals to total-return investors.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
UNH — Risks
- Thin margins leave less room for operational missteps.
UNH — Summary
UnitedHealth Group Incorporated (UNH) is a mega-cap Healthcare company focused on Healthcare Plans, listed on NYQ. Last price $403.97 with market cap $366.86B. Trailing P/E 31.05×. Revenue grew 0.4% year-over-year per public data. Notable strengths include earnings growth of 61.5% year-over-year. Key watch items include thin profit margin (3.1%). For analyst estimates, ownership, and live news on UNH, upgrade to Vest Terminal Professional.
UnitedHealth Group Incorporated FAQ
What does UnitedHealth Group Incorporated (UNH) do?
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness…
What is UNH's P/E ratio?
UnitedHealth Group Incorporated has a trailing P/E of 31.05× based on publicly available market data.
Does UNH pay a dividend?
Indicated dividend yield: 2.2%. Confirm ex-dates and payout history in Vest Terminal.
What sector is UNH in?
UnitedHealth Group Incorporated is classified in Healthcare (Healthcare Plans) on NYQ.
What is UNH's market capitalization?
Approximate market cap: $366.86B.
What are the main risks for UNH?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of UNH?
Potential positives include earnings growth of 61.5% year-over-year, positive free cash flow ($22.76b).
Where can I get analyst estimates for UNH?
Consensus estimates, price targets, and detailed analyst data for UnitedHealth Group Incorporated are available to Professional subscribers in Vest Terminal — not on this public summary page.